Search for: "Amphastar Pharmaceuticals, Inc."
Results 21 - 40
of 55
Sorted by Relevance
|
Sort by Date
9 Feb 2018, 7:13 am
Amphastar Pharmaceuticals, Inc., et al, 1-11-cv-11681 (MAD February 7, 2018, Order) (Gorton, USDJ) [read post]
20 Apr 2012, 12:12 pm
.), who left the House in January 2011 after nine terms, is advocating for Amphastar Pharmaceuticals Inc. and the Apache Gaming Board. [read post]
11 Sep 2012, 5:30 am
Amphastar Pharmaceuticals, Inc. has now (alarmingly in my view) further widened the applicability of this “safe harbor” beyond such pre-marketing FDA approval activity. [read post]
17 Feb 2007, 7:58 am
The Orange County Business Journal gives some insights into the Lovenox case: The Amphastar Pharmaceuticals Inc. team's defense took a turn in 2004 when the lawyers said they found that Sanofi may have failed to disclose information about dosage sizes in the data submitted to patent examiners. [read post]
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
7 Jul 2014, 11:34 am
Originally, Amphastar Pharmaceuticals, Inc. and Sanofi-Aventis S.A. battled it out in 2008 in a patent dispute over Sanofi-Aventis’s anticoagulant drug. [read post]
3 Apr 2013, 4:45 am
Amphastar Pharmaceuticals, Inc. has now (alarmingly in my view) further widened the applicability of this “safe harbor” beyond such pre-marketing FDA approval activity. [read post]
3 Apr 2019, 5:15 am
Amphastar Pharmaceutical, Inc., 525 F.3d 1334, 1349 (Fed.Cir.2008). [read post]
29 Aug 2017, 1:17 pm
AMPHASTAR PHARMACEUTICALS, INC., 2017 U.S. [read post]
20 Apr 2009, 2:24 pm
Amphastar Pharmaceuticals, Inc., et al. [read post]
27 May 2013, 7:22 pm
See Pharmaceuticals v. [read post]
7 Aug 2012, 7:43 pm
Amphastar Pharmaceuticals, Inc. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
3 Jun 2016, 6:40 am
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
4 Jan 2013, 7:03 am
Amphastar Pharmaceuticals, Inc., 686 F.3d 1348 (Fed.Cir. 2012). 5. [read post]
10 Jul 2011, 11:29 pm
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
30 Jun 2010, 2:14 pm
The NAN warning states that emergency syringes of epinephrine in 1mg/10mL (0.1 mg/ml) are currently on backorder from the Hospira Inc., the only manufacturer of the product after the pharmaceutical company Amphastar stopped making its emergency syringes of the drug in 2009. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
18 Sep 2016, 6:03 pm
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
